News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
13-Feb-2001 - Novartis Ophthalmics, the eye health unit of Novartis Pharma AG, and QLT Inc. today announced top-line results that showed Visudyne therapy reduces the risk of vision loss in a new population of patients with wet age-related macular degeneration (AMD). The results were from a multi-center ...
12-Feb-2001 - A jury in Delaware found on February 2, 2001 that Clariant Life Science Molecules (Italia), SpA, does not infringe a patent owned by Great Lakes Chemical. Clariant Life Science Molecules (Italia), SpA, which was formerly known as "Archimica", is pleased with the decision of the jury in finding ...
09-Feb-2001 - Yale School of Medicine’s International Health Program, which sends U.S. physicians-in-training to countries in the developing world, will expand with funding from Johnson & Johnson. The Yale International Health Program (IHP) was founded in 1981 by Michele Barry, M.D., and Frank Bia, ...
08-Feb-2001 - Shell Hydrogen, Hydro-Québec (HQ) and Gesellschaft für Elektrometallurgie (GfE) today announced plans to establish a joint venture for developing, manufacturing and marketing hydrogen storage products. Safe and convenient storage of hydrogen is crucial for the introduction of hydrogen into ...
06-Feb-2001 - Since the beginning of this year, BASF has been following new paths in its innovation endeavors for the plastics sector: the recently founded "Thermoplastics Applications Research" unit has been given the task of tapping into new areas of application for engineering plastics. This comprises ...
05-Feb-2001 - Aventis and the Nobel Foundation announced today a new collaboration to expand the Internet-based Nobel e-Museum (NeM) (www.nobel.se and www.nobelprize.org) as part of the centennial celebration of the Nobel Prize. Aventis, through its Aventis Pharma prescription drugs and Aventis Pasteur ...
05-Feb-2001 - Lexicon Genetics Incorporated (Nasdaq: LEXG) and Abgenix, Inc. (Nasdaq: ABGX) announced today that Lexicon has delivered to Abgenix, thirteen (13) human antigens for antibody development as part of the companies’ drug discovery alliance. This marks the first of many antigens to be delivered to ...
02-Feb-2001 - BioChem Pharma Inc. (NASDAQ: BCHE; TSE: BCH) announces the publication of a peer-reviewed paper regarding Phase I leukemia data on TroxatylTM (troxacitabine) in today’s edition of the Journal of Clinical Oncology. Troxatyl is BioChem’s investigational compound currently in Phase II clinical ...
31-Jan-2001 - It fills all drivers with dread: a scratch in newly polished paint. After all, for most people the exterior of their car is very important. It is supposed to be smooth, sparkling and flawless. But the human eye is an implacable instrument - it discerns even the smallest scratches in a shining ...
Drug restricted in patients until additional safety evaluation resolved
30-Jan-2001 - Pfizer announced today that it has restricted use of its investigational drug capravirine for some patients in clinical trials based on results of a 12-month animal toxicology study, which demonstrated an unexpected finding of vasculitis. This decision was reached in discussions with the FDA ...
© 1997-2024 LUMITOS AG, All rights reserved